U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC… Read More
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. Ruling Will Help Protect… Read More
Lawmakers Should Advance the ETHIC Act and Skinny Labels, Big Savings Act to… Read More
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based… Read More
Report Finds List Prices for Best-Selling Medicare Part D Prescription Drugs… Read More
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More
Pfizer CEO Highlights Delayed Competition on Blockbuster Drug as Reason to Be… Read More
Big Pharma Companies Once Again Beat Earnings Expectations Following Price… Read More
AbbVie CEO Touts Patent Abuse to Extend Exclusivity on Blockbuster Skyrizi,… Read More
Sanofi Touts Patent Thickets, Legal Strategy to Block Competition to Dupixent… Read More
Analysis Demonstrates Tremendous Cost of Anti-Competitive Tactics Like Patent… Read More